Urban Tea Inc. amongst top 5 bottom performers on NASDAQ
The National Association of Securities Dealers Automated Quotations (NASDAQ) Composite Index opened at 14,082.78 on 28th April 2021. Till 1 PM the highest it touched was 14,116.17 and lowest 14,034.70
Top 5 Bottom Performers Till 1 PM:
Urban Tea Inc. (Change -38.36% Priced at $2.8)
Urban Tea, Inc. engages in the supply and distribution of tea beverages and related products. It also markets meals and pastries through its wholly owned subsidiaries. The company was founded on November 28, 2011 and is headquartered in Changsha, China.
Benitec Biopharma Ltd. ADR (Change -24.64% Priced at $4.1)
Benitec Biopharma, Inc. is a development-stage biotechnology company, which focuses on the advancement of novel genetic medicines. The firms proprietary platforms includes DNA-directed RNA interference, or ddRNAi, combines RNA interference, or RNAi, with gene therapy to create medicines that facilitates sustained silencing of disease-causing genes following a single administration. It is developing ddRNAi-based therapeutics for chronic and life-threatening human conditions including Oculopharyngeal Muscular Dystrophy, and Chronic Hepatitis B. The company was founded on April 13, 2020 and is headquartered in Hayward, CA.
Revolution Medicines Inc. (Change -18.95% Priced at $34.6)
Revolution Medicines, Inc. is a clinical-stage precision oncology company focused on developing novel targeted therapies. It engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment regimens to maximize the depth and durability of clinical benefit and circumvent adaptive resistance mechanisms for patients which are dependent on the RAS and mTOR pathway. The company was founded by Mark A. Goldsmith, Kevan Shokat, Martin D. Burke, David L. Pompliano and Michael Fischbach in October 2014 and is headquartered in Redwood City, CA.
Atea Pharmaceuticals Inc. (Change -18.57% Priced at $27.3)
Atea Pharmaceuticals, Inc. is a clinical stage company, which focuses on discovering, developing, and commercializing antiviral therapeutics. Its product pipelines include Coronaviridae, Flaviviridae, and Paramyxovirdae. The company was founded by Jean-Pierre Sommadossi and David Chu in July 2012 and is headquartered in Boston, MA.
Enphase Energy Inc. (Change -14.73% Priced at $145.9)
Enphase Energy, Inc. engages in the design, development, manufacture and sale of micro inverter systems for the solar photovoltaic industry. Its products include IQ 7 Microinverter Series, IQ Battery, IQ Envoy, IQ Microinverter Accessories, IQ Envoy Accessories and Enlighten & Apps. The company was founded by Raghuveer R. Belur and Martin Fornage in March 2006 and is headquartered in Fremont, CA.
